ARTIVION, INC.AORTEarnings & Financial Report
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
AORT Q4 FY2025 Key Financial Metrics
Revenue
$116.0M
Gross Profit
$73.1M
Operating Profit
$10.7M
Net Profit
$2.4M
Gross Margin
63.1%
Operating Margin
9.2%
Net Margin
2.1%
YoY Growth
19.2%
EPS
$0.06
ARTIVION, INC. Q4 FY2025 Financial Summary
ARTIVION, INC. reported revenue of $116.0M (up 19.2% YoY) for Q4 FY2025, with a net profit of $2.4M (up 114.7% YoY) (2.1% margin). Cost of goods sold was $42.8M, operating expenses totaled $62.5M.
Key Financial Metrics
| Total Revenue | $116.0M |
|---|---|
| Net Profit | $2.4M |
| Gross Margin | 63.1% |
| Operating Margin | 9.2% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
ARTIVION, INC. Q4 FY2025 revenue of $116.0M breaks down across 5 segments, led by Aortic Stent Grafts at $43.3M (37.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Aortic Stent Grafts | $43.3M | 37.4% |
| On X | $27.8M | 24.0% |
| Preservation Services | $24.1M | 20.8% |
| Surgical Sealants | $20.3M | 17.5% |
| Other Products | $463.0K | 0.4% |
ARTIVION, INC. Revenue by Segment — Quarterly Trend
ARTIVION, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Aortic Stent Grafts and On X) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Aortic Stent Grafts | $43.3M | $39.6M | — | $36.6M |
| On X | $27.8M | $26.8M | — | $21.6M |
| Preservation Services | $24.1M | $25.7M | — | $20.2M |
| Surgical Sealants | $20.3M | $18.9M | $19.3M | $18.1M |
| Other Products | $463.0K | $2.4M | $2.7M | $2.5M |
ARTIVION, INC. Annual Revenue by Year
ARTIVION, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $441.3M).
ARTIVION, INC. Quarterly Revenue & Net Profit History
ARTIVION, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $116.0M | +19.2% | $2.4M | 2.1% |
| Q3 FY2025 | $113.4M | +18.4% | $6.5M | 5.7% |
| Q2 FY2025 | $113.0M | +15.3% | $1.3M | 1.2% |
| Q1 FY2025 | $99.0M | +1.6% | $-505.0K | -0.5% |
| Q4 FY2024 | $97.3M | +3.9% | $-16.5M | -16.9% |
| Q3 FY2024 | $95.8M | +9.0% | $-2.3M | -2.4% |
| Q2 FY2024 | $98.0M | +9.8% | $-2.1M | -2.2% |
| Q1 FY2024 | $97.4M | +17.1% | $7.5M | 7.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $97.4M | $98.0M | $95.8M | $97.3M | $99.0M | $113.0M | $113.4M | $116.0M |
| YoY Growth | 17.1% | 9.8% | 9.0% | 3.9% | 1.6% | 15.3% | 18.4% | 19.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $784.0M | $789.5M | $803.1M | $789.1M | $791.2M | $838.4M | $857.7M | $884.8M |
| Liabilities | $489.0M | $494.5M | $498.4M | $512.9M | $496.9M | $418.5M | $419.0M | $436.6M |
| Equity | $295.0M | $295.1M | $304.7M | $276.2M | $294.3M | $419.9M | $438.7M | $448.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-5.5M | $6.1M | $11.5M | $10.1M | $-17.0M | $15.0M | $22.3M | $19.6M |